Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLSK - US18452B2097 - Common Stock

14.03 USD
-0.79 (-5.33%)
Last: 12/12/2025, 8:21:52 PM
13.9 USD
-0.13 (-0.93%)
After Hours: 12/12/2025, 8:21:52 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLSK. CLSK was compared to 280 industry peers in the Software industry. CLSK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLSK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CLSK had positive earnings in the past year.
CLSK had a negative operating cash flow in the past year.
CLSK had negative earnings in 4 of the past 5 years.
In the past 5 years CLSK reported 4 times negative operating cash flow.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

With an excellent Return On Assets value of 11.10%, CLSK belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
CLSK's Return On Equity of 16.24% is amongst the best of the industry. CLSK outperforms 83.57% of its industry peers.
Industry RankSector Rank
ROA 11.1%
ROE 16.24%
ROIC N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

CLSK has a better Profit Margin (46.11%) than 94.29% of its industry peers.
CLSK's Gross Margin of 55.23% is on the low side compared to the rest of the industry. CLSK is outperformed by 65.00% of its industry peers.
CLSK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 46.11%
GM 55.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

5

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLSK has more shares outstanding
Compared to 5 years ago, CLSK has more shares outstanding
The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.71 indicates that CLSK is not a great score, but indicates only limited risk for bankruptcy at the moment.
CLSK's Altman-Z score of 2.71 is in line compared to the rest of the industry. CLSK outperforms 56.07% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that CLSK is not too dependend on debt financing.
CLSK's Debt to Equity ratio of 0.30 is in line compared to the rest of the industry. CLSK outperforms 40.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.71
ROIC/WACCN/A
WACC10.6%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CLSK has a Current Ratio of 4.18. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CLSK (4.18) is better than 83.57% of its industry peers.
CLSK has a Quick Ratio of 4.18. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
CLSK has a Quick ratio of 4.18. This is amongst the best in the industry. CLSK outperforms 83.57% of its industry peers.
Industry RankSector Rank
Current Ratio 4.18
Quick Ratio 4.18
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1242.86% over the past year.
CLSK shows a strong growth in Revenue. In the last year, the Revenue has grown by 102.21%.
The Revenue has been growing by 138.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1242.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.3%
Revenue 1Y (TTM)102.21%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%150.52%

3.2 Future

CLSK is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -68.41% yearly.
The Revenue is expected to grow by 28.19% on average over the next years. This is a very strong growth
EPS Next Y-27.34%
EPS Next 2Y2.87%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue Next Year17.36%
Revenue Next 2Y17.45%
Revenue Next 3Y28.19%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

3

4. Valuation

4.1 Price/Earnings Ratio

CLSK is valuated correctly with a Price/Earnings ratio of 14.93.
Compared to the rest of the industry, the Price/Earnings ratio of CLSK indicates a rather cheap valuation: CLSK is cheaper than 82.14% of the companies listed in the same industry.
CLSK is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 20.54, which indicates a rather expensive current valuation of CLSK.
71.43% of the companies in the same industry are more expensive than CLSK, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, CLSK is valued at the same level.
Industry RankSector Rank
PE 14.93
Fwd PE 20.54
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CLSK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLSK is cheaper than 81.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.92
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLSK's earnings are expected to decrease with -68.41% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.87%
EPS Next 3Y-68.41%

0

5. Dividend

5.1 Amount

CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEANSPARK INC

NASDAQ:CLSK (12/12/2025, 8:21:52 PM)

After market: 13.9 -0.13 (-0.93%)

14.03

-0.79 (-5.33%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25 2025-11-25/amc
Earnings (Next)02-04 2026-02-04
Inst Owners79.36%
Inst Owner Change11.39%
Ins Owners1.75%
Ins Owner Change49.57%
Market Cap3.59B
Revenue(TTM)766.31M
Net Income(TTM)353.32M
Analysts83.16
Price Target24.83 (76.98%)
Short Float %28.64%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP3.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.11%
Min EPS beat(2)-103.04%
Max EPS beat(2)171.26%
EPS beat(4)2
Avg EPS beat(4)-59.51%
Min EPS beat(4)-403.92%
Max EPS beat(4)171.26%
EPS beat(8)4
Avg EPS beat(8)77.09%
EPS beat(12)7
Avg EPS beat(12)33.52%
EPS beat(16)7
Avg EPS beat(16)0.36%
Revenue beat(2)1
Avg Revenue beat(2)-3.32%
Min Revenue beat(2)-7.15%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-7.4%
Max Revenue beat(4)4.69%
Revenue beat(8)4
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-2.32%
Revenue beat(16)5
Avg Revenue beat(16)-3.99%
PT rev (1m)-1.47%
PT rev (3m)11.68%
EPS NQ rev (1m)-152.75%
EPS NQ rev (3m)-156.26%
EPS NY rev (1m)-22.1%
EPS NY rev (3m)-20.53%
Revenue NQ rev (1m)-18.88%
Revenue NQ rev (3m)-24.03%
Revenue NY rev (1m)-16.15%
Revenue NY rev (3m)-20.51%
Valuation
Industry RankSector Rank
PE 14.93
Fwd PE 20.54
P/S 4.68
P/FCF N/A
P/OCF N/A
P/B 1.65
P/tB 1.76
EV/EBITDA 18.92
EPS(TTM)0.94
EY6.7%
EPS(NY)0.68
Fwd EY4.87%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-1.8
OCFYN/A
SpS3
BVpS8.51
TBVpS7.97
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.42
Profitability
Industry RankSector Rank
ROA 11.1%
ROE 16.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 46.11%
GM 55.23%
FCFM N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 2.67
Cap/Depr 45.43%
Cap/Sales 20.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.18
Quick Ratio 4.18
Altman-Z 2.71
F-Score4
WACC10.6%
ROIC/WACCN/A
Cap/Depr(3y)67.81%
Cap/Depr(5y)346.78%
Cap/Sales(3y)33.73%
Cap/Sales(5y)94.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1242.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.3%
EPS Next Y-27.34%
EPS Next 2Y2.87%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue 1Y (TTM)102.21%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%150.52%
Revenue Next Year17.36%
Revenue Next 2Y17.45%
Revenue Next 3Y28.19%
Revenue Next 5YN/A
EBIT growth 1Y-78.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.31%
OCF growth 3YN/A
OCF growth 5YN/A

CLEANSPARK INC / CLSK FAQ

What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CLSK.


What is the valuation status for CLSK stock?

ChartMill assigns a valuation rating of 3 / 10 to CLEANSPARK INC (CLSK). This can be considered as Overvalued.


What is the profitability of CLSK stock?

CLEANSPARK INC (CLSK) has a profitability rating of 3 / 10.


Can you provide the financial health for CLSK stock?

The financial health rating of CLEANSPARK INC (CLSK) is 5 / 10.


What is the earnings growth outlook for CLEANSPARK INC?

The Earnings per Share (EPS) of CLEANSPARK INC (CLSK) is expected to decline by -27.34% in the next year.